Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.90 | N/A |
| PEG Ratio (TTM) | 1.60 | N/A |
| P/S Ratio (TTM) | 2.01 | N/A |
| P/B Ratio (TTM) | 0.92 | N/A |
| P/FCF Ratio (TTM) | N/A | N/A |
| Price to 5YR AVG Earnings Ratio | 8.67 | N/A |
| Price to 5YR AVG FCF Ratio | 7.43 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.69% | N/A |
| ROE (TTM) | 9.02% | N/A |
| Net Profit Margin (TTM) | 17.53% | N/A |
| ROIC 5YR AVG | 22.91% | N/A |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 8.44% | 19.12% | 4.37% |
| Revenue | 16.48% | 13.94% | 3.47% |
| Net Income | 7.88% | 19.15% | 3.37% |
| Cash Flow | N/A | 133.05% | 67.82% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.17 | N/A |
| Interest Coverage (TTM) | 0.02 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.48 | N/A |
| LTL to 5YR AVG FCF | 1.38 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.20% | N/A |